Photocure’s PDT Drug-Device Turns Regulatory Corner, Still Needs Funding For Phase III
This article was originally published in The Pink Sheet Daily
Executive Summary
Norwegian biotech hopes to attract development partners for Cevira and its photodynamic acne therapy Visonac by yearend, and is considering its options on an investigational colorectal diagnostic returned by Salix.